Market Place
Sourcing Support
Cellectar Bio Inks Actinium-225 Deal With Ionetix
16 Dec 2025 //
GLOBENEWSWIRE
Alpha-9 Oncology Initiates Phase 1 Trial For A9-3408 In Melanoma
04 Dec 2025 //
PR NEWSWIRE
Actinium Reveals ATNM-400`s Strong Efficacy in Breast Cancer
01 Dec 2025 //
PR NEWSWIRE
AtomVie Delivers First 225Ac-SSO110 Dose for Ariceum Ph1/2 Trial
12 Nov 2025 //
PR NEWSWIRE
Ariceum Doses First Patient In SANTANA-225 Ph1/2 Trial
11 Nov 2025 //
GLOBENEWSWIRE
Nusano, Ariceum Therapeutics Ink Multi-Isotope Supply Deal
14 Oct 2025 //
GLOBENEWSWIRE
Actinium Pharma to Unveil the Multi-Tumor Potential of ATNM-400
13 Oct 2025 //
PR NEWSWIRE
Ariceum Therapeutics Data Backs 225Ac-Sso110 For Small Cell Lung
09 Oct 2025 //
GLOBENEWSWIRE
Cellectar Biosciences, ITM Ink GMP-Grade Actinium-225 Supply Deal
11 Sep 2025 //
GLOBENEWSWIRE
Bayer starts Ph I using Actinium-225 on GPC3 in liver Carcinoma
29 Apr 2025 //
BUSINESSWIRE
ITM, Alpha-9 Oncology Sign Actinium-225 Supply Agreement
24 Apr 2025 //
GLOBENEWSWIRE
Actinium Pharmaceuticals Business Update After Mar-A-Lago Present
27 Mar 2025 //
PR NEWSWIRE
Actinium Pharma Announces ATNM-400 Prostate Cancer Radiotherapy
27 Mar 2025 //
PR NEWSWIRE
NorthStar Medical & Ariceum Announce Actinium-225 Supply Agreement
11 Dec 2024 //
BUSINESSWIRE
Actineer Begins Production Of Actinium-225 Joint Venture
18 Oct 2024 //
BUSINESSWIRE
TerraPower Isotopes Brings Actinium-225 to Market
01 Oct 2024 //
BUSINESSWIRE
BWXT And NorthStar Sign Supply Deal For Actinium-225 Production
22 Jul 2024 //
BUSINESSWIRE
IONETIX Produces First Batch of Actinium-225
07 Jun 2024 //
PR NEWSWIRE
BWXT Submits Actinium-225 API Drug Master File To FDA
07 Jun 2024 //
BUSINESSWIRE
NorthStar Medical Radioisotopes and Alpha-9 Oncology Enter Strategic Agreement
08 Jan 2024 //
BUSINESSWIRE
RayzeBio Completes Phase 1b Enrollment in ACTION-1 Study, Evaluating RYZ101
20 Mar 2023 //
BUSINESSWIRE
RayzeBio Advances RYZ101, into Clinical Development for Two Cancer Indications
13 Sep 2022 //
BUSINESSWIRE
Aktis Oncology Announces Actinium-225 Supply Agreements with Isotope Producers
23 Aug 2022 //
PRNEWSWIRE
Nihon Medi-Physics Attains World`s First Mfg of Actinium-225 with Cyclotron
05 Apr 2022 //
PRNEWSWIRE
Fusion Pharma to Present Preclinical Data Supporting FPI-1966 & FPI-2059
20 Oct 2021 //
PRNEWSWIRE
BWXT Medical & Bayer Sign Agreement for Development & Production of Actinium-225
16 Sep 2021 //
BUSINESSWIRE
TerraPower and Cardinal Health announce agreement for Actinium-225
12 Aug 2021 //
WEBWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.